Miguelina Matthews PhD

Dr. Miguelina Matthews serves as Head of Quality Intelligence, Advocacy & Pharmacopoeia Affairs in Global Quality at Sanofi, bringing over 20 years of pharmaceutical industry expertise across vaccines, small molecules, consumer healthcare products, and medical devices. In her leadership role, Miguelina acts as the liaison between Sanofi and key regulatory health authorities, trade associations, and industry groups, actively influencing the development of regulations, guidance, policy, and pharmacopoeia initiatives. She leads a team responsible for critically analyzing emerging regulatory and pharmacopeia requirements, clarifying the existing regulatory framework to inform internal compliance strategies, and proactively advocating for Sanofi's priority quality issues. Miguelina holds a PhD in Microbial Pathogenesis from Yale University.